Trump is reportedly trying to lure a German company working on coronavirus vaccine exclusively to the U.S.


No one can fault President Trump for wanting Americans to have access to a coronavirus vaccine in the future, but Germany isn't pleased with the way he's reportedly trying to do it.
Per Reuters, Germany's health ministry confirmed a report from German Newspaper Welt am Sonntag that said Trump has offered funds to lure biopharmaceutical company CureVac, which is working on developing a vaccine for the new virus, from Germany to the United States. Welt am Sonntag quoted an anonymous German official who said Trump would do anything to get a vaccine, "but only for the United States."
A German health ministry official, meanwhile, said Berlin wants to make sure vaccines and other substances that could be used to fight off the coronavirus are developed in Germany and Europe, as well. Above all, the hope is to avoid exclusivity.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
"The exclusive sale of a possible vaccine to the USA must be prevented by all means," tweeted Karl Lauterbach, a professor of health economics epidemiology and German lawmaker, in response to the report. "Capitalism has limits."
There was no immediate comment from the U.S. embassy in Berlin, and CureVac declined to comment, but the company's CEO Daniel Menichella met with Trump, Vice Presidnet Mike Pence, and other members of the White House Coronavirus Task Force earlier this month.
CureVac is narrowing its field of vaccine candidates, and hopes to begin testing in June or July. Read more at Reuters.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
September 2 editorial cartoons
Cartoons Tuesday's political cartoons include Labor Day redefined, an exodus from the CDC, and Donald Trump shouting down rumors
-
The trial of Jair Bolsonaro, the 'Trump of the tropics'
The Explainer Brazil's former president will likely be found guilty of attempting military coup, despite US pressure and Trump allegiance
-
Telephobia: why young people are being taught how to make phone calls
In The Spotlight Young people are so scared of calls that they 'scream' when their phone rings
-
New York court tosses Trump's $500M fraud fine
Speed Read A divided appeals court threw out a hefty penalty against President Trump for fraudulently inflating his wealth
-
Trump said to seek government stake in Intel
Speed Read The president and Intel CEO Lip-Bu Tan reportedly discussed the proposal at a recent meeting
-
Switzerland could experience unique economic problems from Trump's tariffs
In the Spotlight The current US tariff rate on Switzerland is among the highest in the world
-
US to take 15% cut of AI chip sales to China
Speed Read Nvidia and AMD will pay the Trump administration 15% of their revenue from selling artificial intelligence chips to China
-
Jaguar's Adrian Mardell steps down: a Maga mauling
Speed Read Jaguar Land Rover had come under fire for 'woke' advertising campaign
-
NFL gets ESPN stake in deal with Disney
Speed Read The deal gives the NFL a 10% stake in Disney's ESPN sports empire and gives ESPN ownership of NFL Network
-
Is Trump's tariffs plan working?
Today's Big Question Trump has touted 'victories', but inflation is the 'elephant in the room'
-
Samsung to make Tesla chips in $16.5B deal
Speed Read Tesla has signed a deal to get its next-generation chips from Samsung